APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nano-antibody CDMO Services

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nano-antibody CDMO Services Industry Growth and Trends Forecast to 2032

23 December 2025123 pages

Choose your research edition.

Industry ResearchNano-antibody CDMO Services Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Nano-antibody CDMO Services Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Nano-antibody CDMO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nano-antibody CDMO Services Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Nano-antibody CDMO Services Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

According to APO Research, the global Nano-antibody CDMO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nano-antibody CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nano-antibody CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nano-antibody CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Nano-antibody CDMO Services market include Nuoanjian Biotech, BioInno Biotechnology, Sanofi, Medicilon, Bioworkshops, Yaohai Bio, Abace Biotechnology, Shilpa Biologicals Private and ProBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nano-antibody CDMO Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nano-antibody CDMO Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nano-antibody CDMO Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nano-antibody CDMO Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Nano-antibody CDMO Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nano-antibody CDMO Services Market by Company

Nuoanjian Biotech

BioInno Biotechnology

Sanofi

Medicilon

Bioworkshops

Yaohai Bio

Abace Biotechnology

Shilpa Biologicals Private

ProBio

PolyPeptide

Pierre Fabre

PeptiFinder Biotech

Jotbody

ImmunoPrecise Antibodies

GenScript

Cultiply

CordenPharma

Bachem

Abzena

53Biologics

Nano-antibody CDMO Services Segment by Type

Vector Construction

Antigen Design

Gene Synthesis

Others

Nano-antibody CDMO Services Segment by Application

Pharmaceutical Companies

Biological Laboratories

Others

Nano-antibody CDMO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nano-antibody CDMO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nano-antibody CDMO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nano-antibody CDMO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Nano-antibody CDMO Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Nano-antibody CDMO Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Nano-antibody CDMO Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Nano-antibody CDMO Services Market Share by Region (2021-2026) Table 4. Global Nano-antibody CDMO Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Nano-antibody CDMO Services Market Share by Region (2027-2032) Table 6. Global Nano-antibody CDMO Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Nano-antibody CDMO Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Nano-antibody CDMO Services Market Size Share by Type (2021-2026) Table 9. Global Nano-antibody CDMO Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Nano-antibody CDMO Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Nano-antibody CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Nano-antibody CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Nano-antibody CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Nano-antibody CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Nano-antibody CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Nano-antibody CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Nano-antibody CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Nano-antibody CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Nano-antibody CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Nano-antibody CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Nano-antibody CDMO Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Nano-antibody CDMO Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Nano-antibody CDMO Services Market Size Share by Application (2021-2026) Table 24. Global Nano-antibody CDMO Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Nano-antibody CDMO Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Nano-antibody CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Nano-antibody CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Nano-antibody CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Nano-antibody CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Nano-antibody CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Nano-antibody CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Nano-antibody CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Nano-antibody CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Nano-antibody CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Nano-antibody CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Nano-antibody CDMO Services Industry Trends Table 37. Nano-antibody CDMO Services Industry Drivers Table 38. Nano-antibody CDMO Services Industry Opportunities and Challenges Table 39. Nano-antibody CDMO Services Industry Restraints Table 40. Global Nano-antibody CDMO Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Nano-antibody CDMO Services Revenue Market Share by Company (2021-2026) Table 42. Global Nano-antibody CDMO Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Nano-antibody CDMO Services Key Company Headquarters & Area Served Table 44. Global Nano-antibody CDMO Services Company, Product Type & Application Table 45. Global Nano-antibody CDMO Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Nano-antibody CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Nuoanjian Biotech Company Information Table 49. Nuoanjian Biotech Business Overview Table 50. Nuoanjian Biotech Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Nuoanjian Biotech Nano-antibody CDMO Services Product Portfolio Table 52. Nuoanjian Biotech Recent Development Table 53. BioInno Biotechnology Company Information Table 54. BioInno Biotechnology Business Overview Table 55. BioInno Biotechnology Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. BioInno Biotechnology Nano-antibody CDMO Services Product Portfolio Table 57. BioInno Biotechnology Recent Development Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sanofi Nano-antibody CDMO Services Product Portfolio Table 62. Sanofi Recent Development Table 63. Medicilon Company Information Table 64. Medicilon Business Overview Table 65. Medicilon Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Medicilon Nano-antibody CDMO Services Product Portfolio Table 67. Medicilon Recent Development Table 68. Bioworkshops Company Information Table 69. Bioworkshops Business Overview Table 70. Bioworkshops Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Bioworkshops Nano-antibody CDMO Services Product Portfolio Table 72. Bioworkshops Recent Development Table 73. Yaohai Bio Company Information Table 74. Yaohai Bio Business Overview Table 75. Yaohai Bio Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Yaohai Bio Nano-antibody CDMO Services Product Portfolio Table 77. Yaohai Bio Recent Development Table 78. Abace Biotechnology Company Information Table 79. Abace Biotechnology Business Overview Table 80. Abace Biotechnology Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Abace Biotechnology Nano-antibody CDMO Services Product Portfolio Table 82. Abace Biotechnology Recent Development Table 83. Shilpa Biologicals Private Company Information Table 84. Shilpa Biologicals Private Business Overview Table 85. Shilpa Biologicals Private Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Shilpa Biologicals Private Nano-antibody CDMO Services Product Portfolio Table 87. Shilpa Biologicals Private Recent Development Table 88. ProBio Company Information Table 89. ProBio Business Overview Table 90. ProBio Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. ProBio Nano-antibody CDMO Services Product Portfolio Table 92. ProBio Recent Development Table 93. PolyPeptide Company Information Table 94. PolyPeptide Business Overview Table 95. PolyPeptide Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. PolyPeptide Nano-antibody CDMO Services Product Portfolio Table 97. PolyPeptide Recent Development Table 98. Pierre Fabre Company Information Table 99. Pierre Fabre Business Overview Table 100. Pierre Fabre Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Pierre Fabre Nano-antibody CDMO Services Product Portfolio Table 102. Pierre Fabre Recent Development Table 103. PeptiFinder Biotech Company Information Table 104. PeptiFinder Biotech Business Overview Table 105. PeptiFinder Biotech Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. PeptiFinder Biotech Nano-antibody CDMO Services Product Portfolio Table 107. PeptiFinder Biotech Recent Development Table 108. Jotbody Company Information Table 109. Jotbody Business Overview Table 110. Jotbody Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Jotbody Nano-antibody CDMO Services Product Portfolio Table 112. Jotbody Recent Development Table 113. ImmunoPrecise Antibodies Company Information Table 114. ImmunoPrecise Antibodies Business Overview Table 115. ImmunoPrecise Antibodies Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. ImmunoPrecise Antibodies Nano-antibody CDMO Services Product Portfolio Table 117. ImmunoPrecise Antibodies Recent Development Table 118. GenScript Company Information Table 119. GenScript Business Overview Table 120. GenScript Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. GenScript Nano-antibody CDMO Services Product Portfolio Table 122. GenScript Recent Development Table 123. Cultiply Company Information Table 124. Cultiply Business Overview Table 125. Cultiply Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Cultiply Nano-antibody CDMO Services Product Portfolio Table 127. Cultiply Recent Development Table 128. CordenPharma Company Information Table 129. CordenPharma Business Overview Table 130. CordenPharma Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. CordenPharma Nano-antibody CDMO Services Product Portfolio Table 132. CordenPharma Recent Development Table 133. Bachem Company Information Table 134. Bachem Business Overview Table 135. Bachem Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Bachem Nano-antibody CDMO Services Product Portfolio Table 137. Bachem Recent Development Table 138. Abzena Company Information Table 139. Abzena Business Overview Table 140. Abzena Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Abzena Nano-antibody CDMO Services Product Portfolio Table 142. Abzena Recent Development Table 143. 53Biologics Company Information Table 144. 53Biologics Business Overview Table 145. 53Biologics Nano-antibody CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. 53Biologics Nano-antibody CDMO Services Product Portfolio Table 147. 53Biologics Recent Development Table 148. North America Nano-antibody CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Nano-antibody CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Nano-antibody CDMO Services Market Share by Country (2021-2026) Table 151. North America Nano-antibody CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Nano-antibody CDMO Services Market Share Forecast by Country (2027-2032) Table 153. Europe Nano-antibody CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Nano-antibody CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Nano-antibody CDMO Services Market Share by Country (2021-2026) Table 156. Europe Nano-antibody CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Nano-antibody CDMO Services Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Nano-antibody CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Nano-antibody CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Nano-antibody CDMO Services Market Share by Country (2021-2026) Table 161. Asia-Pacific Nano-antibody CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Nano-antibody CDMO Services Market Share Forecast by Country (2027-2032) Table 163. Latin America Nano-antibody CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Nano-antibody CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Nano-antibody CDMO Services Market Share by Country (2021-2026) Table 166. Latin America Nano-antibody CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Nano-antibody CDMO Services Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Nano-antibody CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Nano-antibody CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Nano-antibody CDMO Services Market Share by Country (2021-2026) Table 171. Middle East & Africa Nano-antibody CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Nano-antibody CDMO Services Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Nano-antibody CDMO Services Product Image Figure 3. Global Nano-antibody CDMO Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Nano-antibody CDMO Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Nano-antibody CDMO Services Market Share by Region: 2025 VS 2032 Figure 6. Global Nano-antibody CDMO Services Market Share by Region (2021-2032) Figure 7. North America Nano-antibody CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Nano-antibody CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Nano-antibody CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Nano-antibody CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Nano-antibody CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Vector Construction Image Figure 13. Global Vector Construction Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Antigen Design Image Figure 15. Global Antigen Design Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Gene Synthesis Image Figure 17. Global Gene Synthesis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Nano-antibody CDMO Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Nano-antibody CDMO Services Market Share by Type 2025 VS 2032 Figure 22. North America Nano-antibody CDMO Services Market Size Share by Type (2021-2032) Figure 23. Europe Nano-antibody CDMO Services Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Nano-antibody CDMO Services Market Size Share by Type (2021-2032) Figure 25. Latin America Nano-antibody CDMO Services Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Nano-antibody CDMO Services Market Size Share by Type (2021-2032) Figure 27. Pharmaceutical Companies Image Figure 28. Global Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Biological Laboratories Image Figure 30. Global Biological Laboratories Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Nano-antibody CDMO Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Nano-antibody CDMO Services Market Share by Application 2025 VS 2032 Figure 35. North America Nano-antibody CDMO Services Market Size Share by Application (2021-2032) Figure 36. Europe Nano-antibody CDMO Services Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Nano-antibody CDMO Services Market Size Share by Application (2021-2032) Figure 38. Latin America Nano-antibody CDMO Services Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Nano-antibody CDMO Services Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Nano-antibody CDMO Services Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Nano-antibody CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Nano-antibody CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Nano-antibody CDMO Services Market Share by Country (2021-2032) Figure 45. Europe Nano-antibody CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Nano-antibody CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Nano-antibody CDMO Services Market Share by Country (2021-2032) Figure 48. Asia-Pacific Nano-antibody CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Nano-antibody CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Nano-antibody CDMO Services Market Share by Country (2021-2032) Figure 51. Latin America Nano-antibody CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Nano-antibody CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Nano-antibody CDMO Services Market Share by Country (2021-2032) Figure 54. Middle East & Africa Nano-antibody CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Nano-antibody CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Nano-antibody CDMO Services Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Vector Construction
  • Antigen Design
  • Gene Synthesis
  • Others
Applications
  • Pharmaceutical Companies
  • Biological Laboratories
  • Others
Companies covered
  • Nuoanjian Biotech
  • BioInno Biotechnology
  • Sanofi
  • Medicilon
  • Bioworkshops
  • Yaohai Bio
  • Abace Biotechnology
  • Shilpa Biologicals Private
  • ProBio
  • PolyPeptide
  • Pierre Fabre
  • PeptiFinder Biotech
  • Jotbody
  • ImmunoPrecise Antibodies
  • GenScript
  • Cultiply
  • CordenPharma
  • Bachem
  • Abzena
  • 53Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Nano-antibody CDMO Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Nano-antibody CDMO Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Nano-antibody CDMO Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Nano-antibody CDMO Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Nano-antibody CDMO Services Market Size (2021-2032)
  8. 1.5.1 North America Nano-antibody CDMO Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Nano-antibody CDMO Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Nano-antibody CDMO Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Nano-antibody CDMO Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Nano-antibody CDMO Services Market Size Growth Rate (2021-2032)
2 Nano-antibody CDMO Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Vector Construction
  3. 2.1.2 Antigen Design
  4. 2.1.3 Gene Synthesis
  5. 2.1.4 Others
  6. 2.2 Global Nano-antibody CDMO Services Market Size by Type
  7. 2.2.1 Global Nano-antibody CDMO Services Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Nano-antibody CDMO Services Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Nano-antibody CDMO Services Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Nano-antibody CDMO Services Market Size by Regions
  11. 2.3.1 North America Nano-antibody CDMO Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Nano-antibody CDMO Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Nano-antibody CDMO Services Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Nano-antibody CDMO Services Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Nano-antibody CDMO Services Market Size Breakdown by Type (2021-2026)
3 Nano-antibody CDMO Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Companies
  3. 3.1.2 Biological Laboratories
  4. 3.1.3 Others
  5. 3.2 Global Nano-antibody CDMO Services Market Size by Application
  6. 3.2.1 Global Nano-antibody CDMO Services Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Nano-antibody CDMO Services Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Nano-antibody CDMO Services Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Nano-antibody CDMO Services Market Size by Regions
  10. 3.3.1 North America Nano-antibody CDMO Services Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Nano-antibody CDMO Services Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Nano-antibody CDMO Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Nano-antibody CDMO Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Nano-antibody CDMO Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Nano-antibody CDMO Services Industry Trends
  2. 4.2 Nano-antibody CDMO Services Industry Drivers
  3. 4.3 Nano-antibody CDMO Services Industry Opportunities and Challenges
  4. 4.4 Nano-antibody CDMO Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Nano-antibody CDMO Services Revenue (2021-2026)
  2. 5.2 Global Nano-antibody CDMO Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Nano-antibody CDMO Services Key Company Headquarters & Area Served
  4. 5.4 Global Nano-antibody CDMO Services Company, Product Type & Application
  5. 5.5 Global Nano-antibody CDMO Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Nano-antibody CDMO Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Nano-antibody CDMO Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Nano-antibody CDMO Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Nuoanjian Biotech
  2. 6.1.1 Nuoanjian Biotech Company Information
  3. 6.1.2 Nuoanjian Biotech Business Overview
  4. 6.1.3 Nuoanjian Biotech Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Nuoanjian Biotech Nano-antibody CDMO Services Product Portfolio
  6. 6.1.5 Nuoanjian Biotech Recent Developments
  7. 6.2 BioInno Biotechnology
  8. 6.2.1 BioInno Biotechnology Company Information
  9. 6.2.2 BioInno Biotechnology Business Overview
  10. 6.2.3 BioInno Biotechnology Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 BioInno Biotechnology Nano-antibody CDMO Services Product Portfolio
  12. 6.2.5 BioInno Biotechnology Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Nano-antibody CDMO Services Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Medicilon
  20. 6.4.1 Medicilon Company Information
  21. 6.4.2 Medicilon Business Overview
  22. 6.4.3 Medicilon Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Medicilon Nano-antibody CDMO Services Product Portfolio
  24. 6.4.5 Medicilon Recent Developments
  25. 6.5 Bioworkshops
  26. 6.5.1 Bioworkshops Company Information
  27. 6.5.2 Bioworkshops Business Overview
  28. 6.5.3 Bioworkshops Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Bioworkshops Nano-antibody CDMO Services Product Portfolio
  30. 6.5.5 Bioworkshops Recent Developments
  31. 6.6 Yaohai Bio
  32. 6.6.1 Yaohai Bio Company Information
  33. 6.6.2 Yaohai Bio Business Overview
  34. 6.6.3 Yaohai Bio Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Yaohai Bio Nano-antibody CDMO Services Product Portfolio
  36. 6.6.5 Yaohai Bio Recent Developments
  37. 6.7 Abace Biotechnology
  38. 6.7.1 Abace Biotechnology Company Information
  39. 6.7.2 Abace Biotechnology Business Overview
  40. 6.7.3 Abace Biotechnology Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Abace Biotechnology Nano-antibody CDMO Services Product Portfolio
  42. 6.7.5 Abace Biotechnology Recent Developments
  43. 6.8 Shilpa Biologicals Private
  44. 6.8.1 Shilpa Biologicals Private Company Information
  45. 6.8.2 Shilpa Biologicals Private Business Overview
  46. 6.8.3 Shilpa Biologicals Private Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Shilpa Biologicals Private Nano-antibody CDMO Services Product Portfolio
  48. 6.8.5 Shilpa Biologicals Private Recent Developments
  49. 6.9 ProBio
  50. 6.9.1 ProBio Company Information
  51. 6.9.2 ProBio Business Overview
  52. 6.9.3 ProBio Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 ProBio Nano-antibody CDMO Services Product Portfolio
  54. 6.9.5 ProBio Recent Developments
  55. 6.10 PolyPeptide
  56. 6.10.1 PolyPeptide Company Information
  57. 6.10.2 PolyPeptide Business Overview
  58. 6.10.3 PolyPeptide Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 PolyPeptide Nano-antibody CDMO Services Product Portfolio
  60. 6.10.5 PolyPeptide Recent Developments
  61. 6.11 Pierre Fabre
  62. 6.11.1 Pierre Fabre Company Information
  63. 6.11.2 Pierre Fabre Business Overview
  64. 6.11.3 Pierre Fabre Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Pierre Fabre Nano-antibody CDMO Services Product Portfolio
  66. 6.11.5 Pierre Fabre Recent Developments
  67. 6.12 PeptiFinder Biotech
  68. 6.12.1 PeptiFinder Biotech Company Information
  69. 6.12.2 PeptiFinder Biotech Business Overview
  70. 6.12.3 PeptiFinder Biotech Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 PeptiFinder Biotech Nano-antibody CDMO Services Product Portfolio
  72. 6.12.5 PeptiFinder Biotech Recent Developments
  73. 6.13 Jotbody
  74. 6.13.1 Jotbody Company Information
  75. 6.13.2 Jotbody Business Overview
  76. 6.13.3 Jotbody Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Jotbody Nano-antibody CDMO Services Product Portfolio
  78. 6.13.5 Jotbody Recent Developments
  79. 6.14 ImmunoPrecise Antibodies
  80. 6.14.1 ImmunoPrecise Antibodies Company Information
  81. 6.14.2 ImmunoPrecise Antibodies Business Overview
  82. 6.14.3 ImmunoPrecise Antibodies Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 ImmunoPrecise Antibodies Nano-antibody CDMO Services Product Portfolio
  84. 6.14.5 ImmunoPrecise Antibodies Recent Developments
  85. 6.15 GenScript
  86. 6.15.1 GenScript Company Information
  87. 6.15.2 GenScript Business Overview
  88. 6.15.3 GenScript Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 GenScript Nano-antibody CDMO Services Product Portfolio
  90. 6.15.5 GenScript Recent Developments
  91. 6.16 Cultiply
  92. 6.16.1 Cultiply Company Information
  93. 6.16.2 Cultiply Business Overview
  94. 6.16.3 Cultiply Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Cultiply Nano-antibody CDMO Services Product Portfolio
  96. 6.16.5 Cultiply Recent Developments
  97. 6.17 CordenPharma
  98. 6.17.1 CordenPharma Company Information
  99. 6.17.2 CordenPharma Business Overview
  100. 6.17.3 CordenPharma Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 CordenPharma Nano-antibody CDMO Services Product Portfolio
  102. 6.17.5 CordenPharma Recent Developments
  103. 6.18 Bachem
  104. 6.18.1 Bachem Company Information
  105. 6.18.2 Bachem Business Overview
  106. 6.18.3 Bachem Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Bachem Nano-antibody CDMO Services Product Portfolio
  108. 6.18.5 Bachem Recent Developments
  109. 6.19 Abzena
  110. 6.19.1 Abzena Company Information
  111. 6.19.2 Abzena Business Overview
  112. 6.19.3 Abzena Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Abzena Nano-antibody CDMO Services Product Portfolio
  114. 6.19.5 Abzena Recent Developments
  115. 6.20 53Biologics
  116. 6.20.1 53Biologics Company Information
  117. 6.20.2 53Biologics Business Overview
  118. 6.20.3 53Biologics Nano-antibody CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 53Biologics Nano-antibody CDMO Services Product Portfolio
  120. 6.20.5 53Biologics Recent Developments
7 North America
  1. 7.1 North America Nano-antibody CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Nano-antibody CDMO Services Market Size by Country (2021-2026)
  3. 7.3 North America Nano-antibody CDMO Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Nano-antibody CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Nano-antibody CDMO Services Market Size by Country (2021-2026)
  3. 8.3 Europe Nano-antibody CDMO Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Nano-antibody CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Nano-antibody CDMO Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Nano-antibody CDMO Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Nano-antibody CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Nano-antibody CDMO Services Market Size by Country (2021-2026)
  3. 10.3 South America Nano-antibody CDMO Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Nano-antibody CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Nano-antibody CDMO Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Nano-antibody CDMO Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst